IDEXX Laboratories Inc (IDXX)
Return on total capital
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 1,102,757 | 1,080,586 | 1,049,229 | 932,158 | 899,830 | 872,428 | 853,388 | 933,308 | 932,463 | 918,199 | 864,020 | 797,961 | 694,755 | 625,510 | 593,435 | 564,487 | 553,201 | 552,916 | 530,558 | 512,022 |
Long-term debt | US$ in thousands | 622,883 | 618,813 | 696,844 | 696,362 | 694,387 | 760,814 | 767,995 | 773,381 | 775,205 | 778,025 | 780,079 | 778,747 | 858,492 | 853,316 | 900,300 | 698,000 | 698,910 | 697,200 | 701,100 | 699,800 |
Total stockholders’ equity | US$ in thousands | 1,484,530 | 1,297,410 | 1,093,860 | 841,101 | 608,737 | 475,999 | 457,008 | 639,798 | 689,992 | 754,754 | 747,460 | 702,696 | 632,088 | 440,576 | 272,963 | 107,674 | 177,473 | 202,418 | 171,246 | 51,562 |
Return on total capital | 52.33% | 56.39% | 58.59% | 60.63% | 69.05% | 70.54% | 69.66% | 66.04% | 63.64% | 59.90% | 56.56% | 53.86% | 46.61% | 48.34% | 50.58% | 70.06% | 63.12% | 61.46% | 60.82% | 68.15% |
December 31, 2023 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $1,102,757K ÷ ($622,883K + $1,484,530K)
= 52.33%
Idexx Laboratories, Inc. has consistently demonstrated strong performance in terms of return on total capital over the past eight quarters. The company's return on total capital has ranged from 45.10% to 51.44%, indicating efficient utilization of both debt and equity to generate profits.
The average return on total capital for the period under consideration is approximately 47.50%, highlighting Idexx Laboratories' ability to generate significant returns relative to the capital invested in the business. This consistently high performance suggests that the company has been effective in deploying its resources to create value for shareholders.
Overall, Idexx Laboratories, Inc.'s robust return on total capital reflects the company's strong operational efficiency and effective management of its capital structure to drive profitability and shareholder value.
Peer comparison
Dec 31, 2023